Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo,…

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio…

Pfizer beats earnings estimates as declining Covid business loses less revenue than expected

Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business performed…

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.…

Generative AI dominates Davos discussions as companies focus on accuracy

Sam Altman, chief executive officer of OpenAI, at the Hope Global Forums annual meeting in Atlanta,…

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

Health care may be a real challenger to tech this year, a business that can actually…

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on…

Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024

For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described…

Here are the big health sector themes to watch next year

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May…

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved…

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this…

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

Investors are contemplating where and when the next big obesity drug deal will occur. At the…

Biden administration asserts power to seize drug patents in move to slash high prices

President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a…

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill…

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and…